Items

HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern Europe (2023-11)

C. Oprea, S. Quirke, I. Lanache, D. Bursa, S. Antoniak, A. Vassilenko, N. Bogdanić, K. Aimla, R. Matulionyte, A. Harxhi, B. Lakatos, L. Fleischhans, N. Rukhadze, D. Sedlacek, G. Dragović-Lukić, A. Verhaz, N. Yancheva, O. Acet, K. Protopapas, J. Kowalska, HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern Europe, HIV MEDICINE, Nov, 2023
Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19) (2021-12)

B. Lakatos, J. Kowalska, S. Antoniak, D. Gokengin, J. Begovac, A. Vassilenko, p. wasilevski, l. fleischhans, D. Lakatos, R. Matulionyte, K. Kase, A. Papadopoulus, N. Rukhadze, A. Harxhi, S. Hofman, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, C. Oprea, Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19), HIV MEDICINE, Vol. 23, No. 1468-1293, pp. 1 - 8, Dec, 2021
Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group (2022-11)

J. Kowalska, C. Bieńkowski, L. Fleischhans, S. Antonjak, A. Skrzat-Klapaczyńska, M. Suchacz, N. Bogdanić, D. Goengin, C. Oprea, I. Karpov, K. Kase, R. Matulionyte, A. Papadopoulus, N. Rukhadze, A. Harxhi, D. Jilich, B. Lakatos, D. Sedlacek, G. Dragović-Lukić, M. Vasyliev, A. Verhaz, N. Yancheva, J. Begovac, . Horban, Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group, Nov, 2022

Items

HIV disease metrics and COVID‐19 infection severity and outcomes in people living with HIV in central and eastern Europe (2023-11)

Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug-drug interactions among HIV-positive patients receiving treatment for coronavirus disease 2019 (COVID-19) (2021-12)

Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study – data from Euroguidelines in Central and Eastern Europe Network Group (2022-11)